Manufacture of pharmaceutical preparations
DENKRA AS
Revenue 2025
NOK 2.8m
Operating profit
NOK 2.7m
Equity
NOK 3.9m
Incorporated
2022
Share capital
NOK 30,000
Roles
Daglig lederRagnar Salmen
Regnskapsfører
Styrets lederHenrik Lund Uth
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| PHARMORE AS | 45.0% | 45.000000 | 2025 |
| INMEDIC GROUP AS | 45.0% | 45.000000 | 2025 |
| HILDE KILEN | 5.0% | 5.000000 | 2025 |
| HARALD EHNEBOM | 5.0% | 5.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.